This opportunity is no longer accepting applications.
grant PAR-23-255

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

The National Cancer Institute is inviting applications for research funding to analyze and integrate existing data to understand cancer risk and outcomes. This initiative seeks innovative studies using clinical, environmental, health, and genomic data to answer important cancer-related scientific questions. Researchers are encouraged to propose new research goals, methods, or data combinations…

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim t…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Application Window Closes: September 7, 2026
Opportunity Released: August 1, 2023
Open for Submission: August 1, 2023
Submission Deadline: September 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.